What is ELTROMBOPAG 50 MG REVOLADE?
ELTROMBOPAG 50 MG REVOLADE Tablet is utilized to treat low platelet tally because of ongoing resistant (idiopathic) thrombocytopenic purpura (ITP) or constant hepatitis C infection (HCV) contamination. It is likewise used to treat serious aplastic sickliness.
Revolade 50mg Tablet is a thrombopoietin agonist. It works by animating the development of new platelets in the blood. The capacity of platelets is to help lessen dying.
How can be used ELTROMBOPAG 50 MG REVOLADE?
It ought to be taken in a portion and span as prompted by the specialist. You may take it on an unfilled stomach. This medication is to be gulped down as an entire. Try not to bite, pulverize or break it. Advise your primary care physician on the off chance that you have any known hypersensitivities to this medicine.
Eltrombopag was at first supported by the U.S. Food and Drug Administration (FDA) on November 20, 2008, for the therapy of thrombocytopenia in individuals with constant resistant (idiopathic) thrombocytopenic purpura who have had a lacking reaction to corticosteroids, immunoglobulin treatment, or splenectomy.
On August 24, 2015, the FDA supported eltrombopag (Promacta for oral suspension) for the treatment of thrombocytopenia in youngsters one year and more established with idiopathic thrombocytopenia who have had a deficient reaction to corticosteroids, immunoglobulins, or splenectomy.
Sides effects of ELTROMBOPAG 50 MG REVOLADE:
The normal results incorporate queasiness, heaving, or runs. Educate your primary care physician on the off chance that you are pregnant or breastfeeding or experiencing liver infections as a portion change might be required. It is protected to use in patients experiencing kidney sicknesses. It isn’t encouraged to drive after accepting this medication as you may feel tipsy making you less ready. For more details click here.
Business trademark:- REVOLADE
Producer: NOVARTIS
Show: Tablet
Strength: 50mg
